Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joost H A Martens

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
The International Journal of Biochemistry & Cell Biology|June 14, 2011
Acute myeloid leukemia: a central role for the ETS factor ERGJoost H A Martens
FEBS Letters|April 15, 2010
The molecular signature of oncofusion proteins in acute myeloid leukemiaJoost H A Martens, Henk G Stunnenberg
Frontiers in Molecular Biosciences|October 27, 2023
Understanding blood development and leukemia using sequencing-based technologies and human cell systemsBranco M H Heuts, Joost H A Martens
Genes & Cancer|September 24, 2011
The decade of the epigenomes?Joost H A Martens, Hendrik G Stunnenberg, Colin Logie
Molecular and Cellular Biology|February 18, 2003
Cascade of distinct histone modifications during collagenase gene activationJoost H A Martens, Matty Verlaan, Eric Kalkhoven, et al.
Experimental Hematology|May 13, 2014
The genome-wide molecular signature of transcription factors in leukemiaKoen H M Prange, Abhishek A Singh, Joost H A Martens
Biochimica Et Biophysica Acta|October 26, 2010
Genome-wide interplay of nuclear receptors with the epigenomeJoost H A Martens, Nagesha A S Rao, Henk G Stunnenberg
Molecular and Cellular Biology|March 23, 2002
Scaffold/matrix attachment region elements interact with a p300-scaffold attachment factor A complex and are bound by acetylated nucleosomesJoost H A Martens, Matty Verlaan, Eric Kalkhoven, et al.
Epigenetics|October 5, 2020
Recent insights into <i>Histone Acetyltransferase-1</i>: biological function and involvement in pathogenesisAngelita Poziello, Angela Nebbioso, Hendrik G Stunnenberg, et al.
Oncotarget|December 29, 2016
AML associated oncofusion proteins PML-RARA, AML1-ETO and CBFB-MYH11 target RUNX/ETS-factor binding sites to modulate H3ac levels and drive leukemogenesisAbhishek A Singh, Amit Mandoli, Koen H M Prange, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
The International Journal of Biochemistry & Cell Biology|June 14, 2011
Acute myeloid leukemia: a central role for the ETS factor ERGJoost H A Martens
FEBS Letters|April 15, 2010
The molecular signature of oncofusion proteins in acute myeloid leukemiaJoost H A Martens, Henk G Stunnenberg
Frontiers in Molecular Biosciences|October 27, 2023
Understanding blood development and leukemia using sequencing-based technologies and human cell systemsBranco M H Heuts, Joost H A Martens
Genes & Cancer|September 24, 2011
The decade of the epigenomes?Joost H A Martens, Hendrik G Stunnenberg, Colin Logie
Molecular and Cellular Biology|February 18, 2003
Cascade of distinct histone modifications during collagenase gene activationJoost H A Martens, Matty Verlaan, Eric Kalkhoven, et al.
Experimental Hematology|May 13, 2014
The genome-wide molecular signature of transcription factors in leukemiaKoen H M Prange, Abhishek A Singh, Joost H A Martens
Biochimica Et Biophysica Acta|October 26, 2010
Genome-wide interplay of nuclear receptors with the epigenomeJoost H A Martens, Nagesha A S Rao, Henk G Stunnenberg
Molecular and Cellular Biology|March 23, 2002
Scaffold/matrix attachment region elements interact with a p300-scaffold attachment factor A complex and are bound by acetylated nucleosomesJoost H A Martens, Matty Verlaan, Eric Kalkhoven, et al.
Epigenetics|October 5, 2020
Recent insights into <i>Histone Acetyltransferase-1</i>: biological function and involvement in pathogenesisAngelita Poziello, Angela Nebbioso, Hendrik G Stunnenberg, et al.
Oncotarget|December 29, 2016
AML associated oncofusion proteins PML-RARA, AML1-ETO and CBFB-MYH11 target RUNX/ETS-factor binding sites to modulate H3ac levels and drive leukemogenesisAbhishek A Singh, Amit Mandoli, Koen H M Prange, et al.
Pageof 9